T here is now considerable evidence that host genetic factors are important in determining the outcome of infection with Mycobacterium tuberculosis (MTB) . The aim of this study was to assess the role of several candidate genes in the variation observed in the immune responses to MTB antigens. In-vitro assays of T-cell proliferation, an in-vivo intradermal delayed hypersensitivity response; cytokine and antibody secretions to several mycobacterial peptide antigens were assessed in healthy, but exposed, West African twins. Candidate gene polymorphisms were typed in the NRAMP1, Vitamin D receptor, IL10, IL4, IL4 receptor and CTLA-4 genes. Variants of the loci IL10 (-1082 G/A), CTLA-4 (49 A/G) and the IL4 receptor (128 A/G) showed significant associations with immune responses to several antigens. T-cell proliferative responses and antibody responses were reduced, TNF-α responses were increased for subjects with the CTLA-4 G allele. The T-cell proliferative responses of subjects with IL10 GA and GG genotypes differed significantly. IL4 receptor AG and GG genotypes also showed significant differences in their T-cell proliferative responses to MTB antigens. These results yield a greater understanding of the genetic mechanisms that underlie the immune responses in tuberculosis and have implications for the design of therapeutic interventions.
Tuberculosis is one of the world's foremost causes of death from a single infectious agent. The World Health Organization declared tuberculosis a global health emergency in 1993 and estimated that 2-3 million people die each year because of tuberculosis, with 95% of these deaths occurring in developing countries (Raviglione et al., 1995) . The burden of tuberculosis in developing countries is compounded by risk factors such as concurrent HIV disease and the rise in prevalence of multidrug resistant strains of Mycobacterium tuberculosis (MTB).
Only 10% of individuals infected with MTB will develop disease (Murray et al., 1990) . In these individuals, the protective immune response appears to be inadequate to combat clinical disease. The wide range of clinical manifestations of tuberculous disease may reflect the diversity of human immune defenses against MTB. The pathology of disease appears largely attributable to the nature of the host immune reactions. The immune response to MTB is thought to consist of both delayed-type hypersensitivity inflammatory mechanisms and a cell-mediated protective T H 1 response. Kaplan and Freedman (1996) suggest that the balance between the inflammatory response and the protective T-cell response determines whether patients develop active disease.
The only vaccine currently available, Bacillus Calmette-Guérin (BCG), has a protective efficacy against pulmonary tuberculosis varying from nil to 80%, possibly due to regional differences in exposure to environmental mycobacteria (Fine, 1995) . Other possible causes include attenuation of the BCG vaccine (Behr et al., 1999) and genetic differences in host populations.
The components of the immune response to MTB are directed against a large and varied number of antigens that are presented by the bacilli during infection. Furthermore, there is evidence that disease progression
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Immune Responses to Tuberculosis in Twins correlates with distinct immune profiles to defined antigens presented at different stages of the disease (Orme et al., 1993) . So as to capture some of this complexity, we examined the in-vitro immune responses to a wide selection of antigens. The heat shock proteins hsp70 or 70kD, hsp65 or 65kD (Young et al., 1987) , and hsp10 or 10kD (Mehra et al., 1992) are among the most prominent of the antigenic proteins recognized by humans. Short-term culture filtrate (STCF) is highly enriched in proteins actively secreted by the bacterium that are important targets for the immune system. The antigens identified in this filtrate include 10kD hsp, antigen85 complex (Ag85) and ESAT6. ESAT6 is a dominant target in the early phase of infection. Antigenic peptides (EG602, EG603) derived from ESAT6 were used in this study.
The 38kD antigen has been shown to induce the most frequent and highest titres of serum antibodies in tuberculosis (Jackett et al., 1988) . Peptides derived from this antigen were used to stimulate T-cell proliferation. Purified protein derivative (PPD) is a crude antigenic mixture prepared from heat-killed MTB cultures, that is widely used to evaluate the immunological response of individuals; two preparations were used in this study, RT48 (Statens Serums Institute, Copenhagen) and PPD supplied by Evans Medical, Horsham, UK (hereafter called 'Evans'). Among the prominent molecules of the mycobacterial cell envelope is the complex lipoglycan, lipoarabinomannan (LAM): this is a potent stimulus for TNF-α release from macrophages. In general, mannose-capped LAM (ManLAM) is associated with the slow-growing species of mycobacteria, while the arabinosylated form (AraLAM) predominates in the fast-growing; AraLAM uses the lipopolysaccharide (LPS gram negative cell wall endotoxin) receptor CD14 to enter the macrophage, whereas ManLAM also uses the mannose receptor (Schlesinger, 1993) . Differential receptor interaction may influence subsequent intracellular signaling and consequent immune response.
The clustering of tuberculosis within families has been reported many times; several studies have demonstrated that siblings of tuberculosis patients were more at risk of dying from tuberculosis than marital partners (Pearson, 1907; Puffer, 1946) . Twin studies have provided convincing evidence for the role of host genetic factors for different infectious diseases (Hill, 1998) . Our previous work demonstrated that invitro immune responses to defined mycobacterial proteins and peptides were also subject to genetic regulation (Jepson et al., 2001) . The question is no longer whether there is a genetic component in the susceptibility to tuberculosis but how, by what mechanism, and to what degree genetic factors determine the response to exposure or disease.
Several studies have now been undertaken to elucidate the key immune response genes that may be involved in susceptibility to tuberculosis. There is substantial evidence for the importance of non-MHC genes in diseases such as malaria (Jepson et al., 1997) , autoimmune diseases (reviewed by Wandstrat & Wakeland, 2001 ) and tuberculosis. Bellamy et al. (1998a Bellamy et al. ( , 1998b first showed that tuberculosis is associated with variation in the NRAMP1 and Vitamin D receptor genes. The aim of the present study was to identify the genes that may be involved in the regulation of the immune responses to tuberculosis antigens (Jepson et al., 2001) . Despite numerous candidate studies of genetic susceptibility to tuberculosis almost nothing is known about specific non-HLA genes that may influence immune responses to mycobacterial antigens in humans. We have recently shown in Gambian twins that several such immune responses show substantial heritability and that most of the genetic component may lie outside the major histocompatibility complex (Jepson et al., 1997 (Jepson et al., , 2001 . In particular, it was demonstrated that memory T-cell responses to secreted mycobacterial antigens (antigen85 complex, STCF and peptides from the ESAT6), as well as to the 65 kD heat shock protein, are subject to effective genetic regulation. The delayed hypersensitivity response to intradermal tuberculin also demonstrated significant genetic variance (Jepson et al., 2001) .
The selection strategy for the candidate genes was based first on their functional importance in the immunological responses occurring during infection with MTB, and second on whether there was accumulating evidence for association with other bacterial and autoimmune diseases. CTLA-4 is a member of the CD28 receptor family; the counterreceptors for these proteins are the B-7 family members, B7-1 and B7-2 expressed on antigen presenting cells. The B7: CD28/CTLA-4 pathway is important in antigen specific T-cell activation, since T-cell activation in the absence of co-stimulation results in development of anergy or cell death (Schwartz, 1990) . The pathway may also play an important role in influencing T-cell differentiation (Battifora et al., 1998; Greenfield et al., 1998) . This has been an important area of study for the T H 2 cell-mediated allergic responses and atopic diseases. In mice, the B7-CD28/CTLA-4 co-stimulatory pathways are required for the development of T H 2 mediated allergic airway responses (Keane-Myers et al., 1997) . There have been several studies showing evidence for an association between CTLA-4 and autoimmune diseases. These include associations between CTLA-4 and Graves diseases (Ueda et al., 2003; Yanagawa et al., 1997) , Hashimoto's thyroiditis (Donner et al., 1997) , diabetes (Ueda et al., 2003) and rheumatoid arthritis in Spanish patients (Gonzalez-Escribano et al., 1999; Seidl et al., 1998) .
IL10 plays a critical role in immune regulation by controlling the balance between an inflammatory and a humoral response. It has stimulatory effects on Bcells, but an inhibitory effect on macrophages and T H 1 cells. IL10 may play a role in suppressing IFN-γ production and concurrent T H 1 cell response in tuber-culosis (Gong et al., 1996) . Furthermore, differential expression of IL10 has been implicated in a number of autoimmune diseases (Rousset et al., 1992) . There are several polymorphisms of single-base substitutions at positions, -1082, -819 and -592 in the promoter region (Eskdale at el. 1998; Turner et al., 1997) . The mutation at position -1082 from G (high responder) to A (low responder) results in a twofold decrease in the production of IL10 (Turner et al., 1997) .
IL4 operates through the bipartite IL4 receptor; the two subunits of IL4R mediate ligand endocytosis in IL4 responsive cells (Lischke et al., 1998) . IL4R is found on B and T-cells, macrophages and mast cells. The importance of IL4 and its receptor in polarizing the T-cell response to a T H 2 immune response indicates that it is a plausible candidate for immune responses in tuberculosis, where a T H 2 response leads to exacerbation of disease. The effects of specific variants of genes encoding the vitamin D receptor, IL4 and NRAMP1 were also tested for these immune responses.
Subjects and Methods
Recruitment for this study was conducted in The Gambia, West Africa between January 1996 and April 1997. Two hundred and eighty-two twin pairs aged 12 to 85 years agreed to participate in the study: all were living in rural villages within four hours drive of one of the three Medical Research Council (MRC) field stations. At the time of blood collection, subjects were also tested for mycobacterial exposure with a tuberculin skin test. The study protocol was approved by the Gambia Government/MRC Ethics Committee, and further details can be found in Jepson et al. (2001) .
Several in-vitro immune assays were conducted to test the wide range of immune responses that might occur in response to invading bacilli. T-cell proliferative responses to several antigens and antigenic peptides were measured using H-thymidine incorporation (Jepson et al., 2001) . A whole blood assay was used to measure TNF-α responses following stimulation by ManLAM and
AraLAM. An enzyme-immunoassay method using a highly specific recombinant 38kD antigen from the MTB was used to detect IgG antibodies in human serum (Jepson et al., 2001) . DNA was extracted from the remaining blood cells using Nucleon II kits as per manufacturer's instructions (Scotlab UK). Zygosity of all twin pairs was determined by typing at least seven independent highly polymorphic microsatellite markers. The genotypes for each of the candidate genes were determined by means of PCR and allele-specific oligonucleotide hybridization.
Frequency distributions for each of the measured in-vitro immune responses were assessed by normal probability plots. T-cell proliferative stimulation indices and IgG responses were log-transformed; a square root transformation was applied to the TNF-α response (pg/ml). All references to the immune responses are to their transformed values.
We fitted a twin path model using Mx (Neale, 1997) to estimate the proportion of variation in T-cell proliferative responses, antibody response and TNF-α production explained by genetic factors. For each immune response, a baseline model was fitted which allowed for additive genetic (A), nonshared environment (E), and either dominant genetic (D) or shared environmental (C) sources of variation. Results from these models have been published previously (Jepson et al., 2001) . In these models, maximum likelihood analyses of individual observations are used to test simultaneously hypotheses about the means, variances and covariances (Martin et al., 1987) . This provides a way of allowing for the effects of covariates, such as sex and age while simultaneously estimating genetic and environmental variance effects (Dolan et al., 1989; Neale & Martin, 1989) . Since association analysis involves looking at mean differences in phenotypes between groups with different marker alleles; it is possible to test the contribution of these polymorphisms to the total genetic variance by including the candidate polymorphisms as covariates in the model as is done for age or sex (Whitfield et al., 2000) . An analysis of association then tests the significance of the quantitative trait locus by removing it from the model, while the residual genetic and environmental variance parameters are allowed to vary. The fit of each submodel, in which the quantitative trait locus is removed is assessed by twice the difference in log likelihood between the full and submodels (MacGregor et al., 1999) . This difference is distributed as χ 2 with degrees of freedom (df) equal to the difference in df between the models.
First, association analysis was carried out under the assumption of additive effects for each of the candidates (allelic model). Further models were tested that allow for the possibility of dominance where the phenotypic value of the heterozygote may be closer to one homozygote than the other. The four models tested were:
Model 1: Allows for an additive allelic effect; for example, for CTLA4 the effect of having two G alleles would be twice as great as that of having one G allele.
Model 2: Allows for the possibility of dominance; for example, for CTLA4 this tests the dominance of the A allele by constraining AG and AA to be equal and different from GG.
Model 3: Allows for the possibility of dominance in the opposite direction; for example, for CTLA4 this tests the dominance of the G allele by constraining AG and GG to be equal and different from AA.
Model 4: Allows for the possibility of partial dominance by estimating unconstrained deviations for two genotypes from the baseline value of the third genotype. This is the most general model with 2 df; models 1-3 differ from it by a single df.
These models were fitted to all variables, including those that had not shown significant heritability in the initial variance components analysis, as this may be due to the lack of power associated with the small number of twins. Only variables for which there was some evidence for association are shown here. Results for fitting model 4 to the data are not shown here because it did not result in improved model fit for any of the antigens.
Mean differences in phenotype as a function of allelic effect could occur from either functional effects of the locus itself, or from linkage disequilibrium with a nearby functional site, or association could be spurious arising from population stratification (Neale et al., 1999) . It is possible to test whether the association is genuine by fitting models in which the association effect is split into a within twin pair-additive deviation, aw and a between-pair component, ab. If aw is not significantly different from zero, or if ab is significantly greater than aw, this suggests that stratification may be present (Fulker et al., 1999) . Sham et al. (2000) have extended this to include between-and within-pair dominance deviations. However, only DZ twin pairs that have either the recessive or dominant genotypes are informative for this test, and for the few variables that showed dominance effects in our study there were too few such pairs. Finally, sources of covariation between the immune response phenotypes were tested in a multivariate model to take advantage of increased power to detect association.
Results Genotyping
The cohort comprised 62 MZ twin pairs and 188 DZ twin pairs. There were 30 pairs of MZ females (MZF), 32 pairs of MZ males (MZM), 78 pairs of DZ females (DZF), 46 pairs of DZ males (DZM) and 64 pairs of opposite sex pairs (DZO). The mean age for the MZ twins was 24.3 6 1.11years, and for DZ twins it was 25.2 6 0.72.
The allele frequencies at each locus (Table 1) were estimated by taking only one subject from each twin pair randomly. The allele frequencies for NRAMP1, vitamin D receptor, IL4 and IL10 are similar to those found in a previous association study of susceptibility to tuberculosis in The Gambia (Bellamy, 1998) . The genotype frequencies did not deviate significantly from those expected under Hardy-Weinberg equilibrium.
CTLA-4
The CTLA-4 exon 1 codon 17 dimorphism (49A/G) corresponding to the amino acid change threonine to alanine was typed. The effects of the A49G polymorphism were tested under the assumption of additive effects (i.e., that the effect of two G alleles would be twice as great as that of one allele). The effect of the polymorphism on the measured immune responses was assessed by comparing the most parsimonious model with means adjusted for allelic effect with the reduced model in which the allelic effect was removed from the model. Dropping the allelic deviation for the G allele from the models resulted in a worsening of model fit for each of the antigens ( Table  2 ). The additive genetic variance decreases for all the variables when the allelic deviation is in the model, which is further evidence of an association (Fulker et al., 1999) . Addition of the allelic effect significantly improved the fit of the model for IgG, even though the estimate of the additive genetic variance was not significant. However, there is greater power to detect genetic mean effects than genetic variance components in these models.
The results of the Fulker test, which is used to assess population stratification as a possible cause of association, are presented in Table 3 . This modeling procedure only makes use of DZ pairs and since the number of subjects is consequently reduced, the analysis will have less power to detect allelic effects than in the full model. Nevertheless, the associations were confirmed as resulting from allelic effects rather than population stratification for all except the antigen ManLAM. The association previously identified between ManLAM and CTLA-4 is not confirmed by the Fulker test, since dropping the within-pair component does not lead to worsening of model fit. This might be attributable to the reduction in sample size and consequent loss of power. The within-and between-pair parameters cannot be equated for STCF, therefore the estimates of association may be influenced to some extent by population substructure. However, there is a large within-family effect, suggesting that the association is genuine.
Interleukin 4 receptor (IL4R)
An IL4 receptor polymorphism that leads to an amino acid change from isoleucine (A) to valine (G) was typed; it is located in the extracellular domain of the receptor and is 148 base pairs from the start codon (Deichmann et al., 1997) . Only STCF showed somewhat significant association under the assump- tion of additivity (∆χ 2 1 = 4.38, p < .05) but this was not confirmed by the within-pairs test (∆χ 2 1 = 1.35, p = .25). However, a genotypic model specifying dominance of the G allele in the increasing direction was found to be significant for 65kD, STCF and RT 48 (Table 4 ). For the EG602 antigen the dominance is significant for the A allele in the decreasing direction (Table 4 ).
Interleukin 10 (IL10)
There are many known polymorphisms in the IL10 gene; three of these (-1082, -819 and -592) in the promoter region are in strong linkage disequilibrium (Bellamy & Hill, 1998a) . The 1082 (G/A) polymorphism was typed in this study, since there is some evidence of it being functional (Turner et al., 1997) . The effect of the IL10 polymorphism was tested first under the assumption of additivity by adding a deviation for the G allele to the models adjusted for covariates. Further models that allowed for the possibility of dominance were also examined.
Eliminating the effects of the IL10 G allele for the PPD reagent RT48 produced a significant worsening of model fit, indicating that the IL10 locus may account for a proportion (1%) of the genetic variance in memory T-cell response to this antigen (Table 5) . This was marginally confirmed by the Fulker test; setting aw = 0 produced ∆χ 2 1 = 3.47, (p = 0.06), the within-family and between-family parameters could also be equated, which suggests that the association is not entirely due to population stratification.
The log likelihood χ 2 difference between the models for the ESAT6 peptide (EG602) indicate that there was no significant allelic effect (χ 2 1 = 0.23) implying that the assumption of additivity does not apply in this case. Fitting genotypic models to these same data suggested dominance of the G allele in the decreasing direction, but the fact that the model specifying this fixed effect has a greater residual variance (a 2 = 0.43) than the model without this deviation (a 2 ' = 0.36) makes this result suspect (Table 5 ).
Other Candidate Genes
The polymorphism typed in the IL4 gene is the IL4 -590 promoter, which is a C to T transition (Rosenwasser et al., 1995) . There was no evidence of any association of IL4 with the immune assays measured in this study. There was also no evidence of an association of the 4bp 'TGTG' insertion/deletion polymorphism in the 3' UTR of NRAMP1 with any of the immune responses to the tuberculosis antigens. Results from modeling an effect of the vitamin D receptor polymorphism T/t variant on the proliferative responses and the TNF-α responses presented no evidence of an association with this polymorphism in this study of Gambian twins. There was also no evidence of any significant effect of the candidate genes on the delayed hypersensitivity skin response. Shown are the proportions of additive variance (a 2 ) for each of the means models, which include a deviation for the G allele of the A49G polymorphism and the same proportion when the allelic deviation is dropped (second model, a 2' ). The percentage of genetic variance explained by the G allele can be estimated from the difference between the a 2 for the full model and a 2 ' from the reduced model. ∆χ 2 is the worsening of fit for the second model compared to the first. The deviation for the G allele is in standard units and its 95% confidence interval is included. 
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Covariation Analysis Between the Proliferative Responses to MTB Antigens
There were highly significant correlations between the proliferative responses to many of the antigens analyzed (Jepson et al., 2001) and this covariation can increase the power of association analyses. Multivariate Cholesky decomposition (Neale & Cardon, 1992) was used as a means of examining the effects of the polymorphisms on these correlations. The allelic effects of CTLA4 in a Cholesky decomposition model for RT48, 'Evans', Antigen 85 complex and STCF were examined. Dropping the CTLA4 covariate from the model separately for each of the antigens resulted in a significant worsening of model fit for RT48 (∆χ 2 1 = 4.043, p = .04), 'Evans' (∆χ 2 1 = 7.034, p = .008) and STCF (∆χ 2 1 = 8.058, p = .005). To determine the effect of the IL4 receptor polymorphism in a multivariate model, a Cholesky decomposition was fitted which allowed for the possibility of dominance effects on the means. This confirmed the dominance effects of the GG homozygote seen in Table 4 , but with increased significance on RT48 (∆χ 2 1 = 4.36, p = .03), and STCF (∆χ 2 1 = 7.72, p = .005).
Discussion
There was a negative association of the CTLA-4 allelic variant (G) with the magnitude of proliferative responses to the 38G01 peptide, 'Evans' and STCF; levels of IgG secreted in response to the 38kD antigen were also reduced for this variant. There was a marginal effect of homozygosity for peptides 8T and EG602; G/G individuals had lower proliferative responses than did either AA or AG subjects suggesting dominance of the A allele in the increasing direction. Interestingly, levels of TNF-α secreted to ManLAM were significantly higher in those with the G variant. Proliferative responses are decreased and TNF response increased for those individuals with the G allele. The Fulker tests confirmed that the CTLA-4 polymorphism appears to have a genuine effect on the immune responses to these antigens, except for ManLAM. The most important of the co-stimulatory pathways required for T-cell activation is the B7: CD28/CTLA-4 pathway, which can stimulate both T H 1 and T H 2 type cells. CTLA-4 is expressed only on activated cells and, since it can transduce an inhibitory signal, its function may be to terminate Tcell activation (Walunas et al., 1994) . Co-stimulatory molecules are thought to play a role in the pathogenesis of infectious diseases, as there is evidence that microbial products can affect their expression (Liu & Janeway, 1991; Saha et al., 1998) .
The effects of CTLA-4 on T-cell differentiation to polarized T-cell subsets is incompletely defined and may be distinct for the disease model investigated. For example, inhibition of the effect of CTLA-4 has been shown to enhance both the T H 1 immune response in a mouse model of BCG infection and in some autoimmunity models, but also the T H 2 response in a model of leishmaniasis (Heinzel & Maier, 1999; Kirman et al., 1999) . These findings suggest that CTLA-4 nonselectively modulates T-cell phenotypes formerly biased by independent events. Reiser and Stadecker (1996) suggest that the importance of this co-stimulatory pathway may be in its role in influencing T-cell differ- Shown are the proportions of variance (a 2 ) for models 2 and 3, which include deviations for the AG and AA genotypes. a 2 ' is the proportion of variance when either AG is constrained to equal GG (model 2) or AG is constrained equal to AA (model 3). ∆χ 2 is the worsening of fit for the submodel as compared to full model with genotypes unconstrained. Deviations from the baseline genotype GG are shown for both the heterozygote AG and homozygote AA. Deviations are in standard units with 95% confidence intervals. entiation into T H 1 and T H 2 cells. Very few functional studies of the CTLA-4 polymorphisms have been carried out. A preliminary study indicated a correlation between the exon 1 (A/G) SNP (typed here) and CTLA4 mRNA levels in PBMC, but this has not been replicated (reviewed by Kristiansen et al., 2000) . The association described between the CTLA-4 exon 1 'G' allele and reduced in-vitro proliferative responses may, therefore, be due to linkage disequilibrium with a nearby gene or a functional variant. Further functional studies of the polymorphism typed in this study are required. In addition it would be of interest to assess associations of the immunological phenotypes studied with the more recently described polymorphisms in the 3' noncoding region of CTLA-4. Such variants appear to be functionally significant and have been associated with several autoimmune diseases including type I diabetes and Grave's disease (Ueda et al., 2003) . The development of naive T-cells into differentiated T H 2 cells is dependent on presence of IL4 in the cytokine environment, itself a T H 2 cytokine, but might also depend on the nature of the antigenic stimulation (O'Garra, 1998); co-stimulatory signals such as those delivered by CD28 may be important too. In fact, CD28 has been shown to enhance the sensitivity of naive T-cells to IL4 by altering the IL4 receptor signaling cascade, thus accelerating differentiation of naive T-cells into T H 2 cells (Kubo et al., 1999) . This provides some evidence that the IL4 receptor may be important in T-cell differentiation. There is also evidence that T H 2 cytokines, such as IL4 may be involved in the downregulation of the T H 1 response in tuberculosis (Schluger et al., 1999; Surcel et al., 1994) . The effects of IL4 are mediated by interactions with its receptor.
IL4 plays a central role in the immunopathogenesis of allergic diseases, and the expression of IL4 receptor on the surface of lymphocytes is increased in certain allergic and autoimmune diseases (Mozo et al., 1998) . Data from both mouse and human cell lines provide some evidence of a functional effect for the polymorphism typed in this study. The Ile50 (Isoleucine variant which corresponds to substitution of allele A in the DNA sequence) variant of the receptor was shown to significantly upregulate receptor response to IL4 with resultant increased activation and increased production of IgE (T H 2 response; Mitsuyasu et al., 1999) . A recent study showed no evidence of an association of this polymorphism with tuberculosis disease per se in West Africans (Cervino et al., 2000) .
In this Gambian twin cohort, the most prominent effect of the IL4 receptor genotype (Ile50Val an A to G substitution) was the major effect of homozygosity of the A50G allele. Individuals with G/G genotypes had much higher proliferative response to RT48, 65kD hsp and STCF than either A/G or A/A subjects. This large effect of the second G allele shows the quantitative dominance of the A allele in the increasing direction. These findings indicate that individuals with A/A genotypes that are thought to have an increased T H 2 Table 5 Tests for the Effects of the IL10 Polymorphism on Stimulation Indices to RT48 and EG602 Shown are the proportions of variance (a 2 ) for the additive and dominance models. The additive model includes a deviation for the G allele; the dominance models include a deviation for the AG and GG genotypes. a 2' is the proportion of variance when either AG is constrained to equal AA (model 2) or AG is constrained equal to GG (model 3). ∆χ 2 is the worsening of fit for submodel as compared to the full model with allelic or genotype effects left unconstrained. Deviations from the baseline genotype AA are shown for both the heterozygote AG and homozygote GG. The deviations are in standard units with 95% confidence intervals.
Model
Parameters RT48 EG602
Additive response may also have a decreased T-cell mediated immune response. RT48 and 'Evans' are both purified protein-derivative mixtures so the expectation is that these would have very similar association profiles. In fact, 'Evans' only approaches significance for association with IL4R and this might be due to the lower numbers of twins tested for their immunological response to 'Evans'. Indeed, proliferative responses to 'Evans' did show an association with this polymorphism in the more powerful multivariate analysis. Unfortunately, tests for the confounding effects of population stratification for the dominance effect of the IL4 receptor were not possible because of the small number of informative DZ pairs. STCF and RT48 showed additive effects for this polymorphism too; these results were confirmed with the more stringent Fulker test.
It has been suggested that IL10 may play a role in tuberculosis by downregulating the T H 1 response, specifically IFNγ production and CTLA-4 expression (Gong et al., 1996) . In fact, IL10-deficient mice have increased antimycobacterial immunity (Murray & Young, 1999) . The 'A' allele of the polymorphism typed in this study, in the promoter region at position -1082, has been found to be associated with decreased IL10 production in patients with Crohn's disease and controls (Koss et al., 2000) , providing evidence that this polymorphism has an effect on cytokine production.
The mutation at position -1082 from a G (high responder) to an A (low responder) results in a twofold decrease in the production of IL10 (Turner et al., 1997) . The -1082 polymorphism has been shown to be associated with several autoimmune diseases (reviewed by Bidwell et al., 1999) . Subjects with GG genotypes (high responders) showed decreased proliferative response to RT48 and the ESAT6 peptide, EG602. These findings suggest that individuals with G/G genotypes have increased levels of IL10 and decreased proliferative response to some mycobacterial antigens. The similarity of immune responses for subjects with A/A and A/G genotypes suggests the quantitative dominance of the 'A' allele. It is possible to speculate that individuals with G/G genotypes may have a decreased T H 1 response that could lead to susceptibility to disease. However, Bellamy (1998) found no association with this polymorphism and disease susceptibility in The Gambia.
The importance of the T H 1/T H 2 balance in determining the outcome of the host immune defense to invading bacilli has been highlighted. Therefore, polymorphisms in genes that affect the polarization of the immune response may have important implications for the outcome of the immune response. If it is biased toward a T H 1 response, the response may be protective; however, a more pronounced T H 2 response may lead to severe pathogenic response. In this regard, this study has demonstrated significant associations with IL4 receptor, IL10 and CTLA-4, which may all play a role in polarizing T-cell responses. Furthermore, there is additional evidence that other genes may influence immune response to tuberculosis, since each of the associations in this study only accounts for a small proportion of the genetic variance of each trait. There are, therefore, likely to be a number of genes with individually small and additive effects.
The hormonally active form of Vitamin D3 inhibits the ability of macrophages to induce T-cell differentiation through an as yet unknown mechanism. It has been shown that Vitamin D differentially regulates B7 expression on macrophages and that this might contribute to its inhibitory effect (Clavreul et al., 1998) . Wilkinson et al. (2000) found that Vitamin D deficiency was associated with active tuberculosis and the combination of this deficiency with TT/Tt genotypes was associated with disease. Bellamy et al. (1999) found that subjects with tt genotypes were resistant to tuberculosis. Therefore, the evidence supporting Vitamin D receptor association with mycobacterial diseases is quite compelling. However, from this study there was little evidence of a role for this locus on Tcell activation. The results from this study may in part be explained by recent findings indicating a role for vitamin D3 in maturation of antigen-presenting cells acting at the very first step of the immune response (Penna & Adorini, 2000; Piemonti et al., 2000) .
The aim of the present study was to assess the effects of several candidate polymorphisms on different immune responses to MTB antigens. This by necessity involved multiple tests; it is therefore difficult to infer in the case of individual variants whether the evidence for association is due to multiple comparisons and chance or a real biological effect. We did not make an adjustment for multiple testing because the purpose of the study was to test several immune-response associations and we believe that for this purpose it is more informative to report all the positive results. We recognize the issue of multiple testing and it has been taken into consideration in the interpretation of the results. Nevertheless there are several findings that support a real biological cause for the positive association results in the present study. Only CTLA-4, IL10 and IL4 receptor showed evidence of associations with many of the antigens. Furthermore, several antigens that are known to be of immunological significance in tuberculosis showed associations with each of the candidates. The increase in power arising from the multivariate analysis further supported some of the trends observed in the univariate analysis. There is some evidence in the literature that almost all the polymorphisms typed in this study may have functional effects, but in each case further functional studies are required. The results encourage further investigation of the associations of the defined CTLA-4, IL4 receptor and the IL10 polymorphisms and immune responses to a variety of mycobacterial and other antigens.
Identification of host genes involved in immune responses to mycobacterial antigens should assist in gaining a better understanding of the pathogenesis of disease and ultimately to new therapeutic strategies. Indeed, modulation of the host response in the fight against mycobacteria may be at the forefront of these strategies. It is likely that for a multifactorial disease, such as tuberculosis, a concurrence of diverse genetic and nongenetic factors are needed in order to reach a threshold level for disease.
